Skip to main content

Month: August 2022

Aspo subsidiary ESL Shipping confirms an additional order for five electric hybrid vessels and establishes a shipping pool

Aspo PlcAugust 23, 2022 at 7 p.m.Inside information Aspo subsidiary ESL Shipping confirms an additional order for five electric hybrid vessels and establishes a shipping pool ESL Shipping’s subsidiary AtoB@C Shipping declares an option and order for five additional vessels from the Indian shipyard Chowgule & Company Private Limited, from which the shipping company has previously ordered seven identical electric hybrid vessels. Of the series of 12 new-generation electric hybrid vessels, every other vessel is sold to a company formed by a group of investors. As previously announced, the total amount of ESL Shipping’s own investment will remain at the size of six vessels and approximately EUR 70 million. The first two of the new vessels are already under construction, and the planned delivery of the first vessel is scheduled for...

Continue reading

Customer.io brings customers a best-in-class email code editor through acquisition of Parcel

Portland, OR, Aug. 23, 2022 (GLOBE NEWSWIRE) —Customer.io, a platform that enables companies to engage in a meaningful way with their customers, has joined forces with Parcel, the leading email code editing platform. Teaming up helps Customer.io fulfill its mission to deliver a world-class experience for both email creators and the lifecycle marketers who use email as a way to communicate with their customers. Parcel will continue to be offered as a separate product, and Customer.io will invest in its continued growth.Today, Customer.io announced the acquisition of Parcel, an email coding platform. By joining forces, Customer.io will offer the most streamlined experience for marketers, designers, and email developers worldwide. Users within Customer.io now have access to the best email code editor available...

Continue reading

Global Precision Medicine Market Generate Revenue of $146.57 billion | $2.68 Billion Invested in R&D Activities in 2021 and is Projected to Expand to $5 Billion by 2028 | SkyQuest

Global Precision Medicine Market was valued at USD 65.89 billion in 2021, and it is expected to reach a value of USD 146.57 billion by 2028, at a CAGR of 12.10% over the forecast period (2022–2028). Westford, Massachusetts, Aug. 23, 2022 (GLOBE NEWSWIRE) — From the last few years, the global precision medicine market has been witnessing a rapid growth, as patients seek therapies that are more tailored to their individual needs. For example, personalized cancer treatment is found to be more effective than those that are not specific to the individual’s tumor. And therapies for heart disease can be tailored to the individual patient’s unique genetic makeup. This, in turn, would help in reducing overall healthcare cost, improve disease diagnostics, reduce time and side effects of medicine, and improve overall treatment outcome at...

Continue reading

LiveToBeHappy Reports Record Second Quarter 2022 Results; 2022 YTD Revenues Increase 35% YoY to $5.4 Million

Company Achieves Net Income Profitability; Reaffirms Full Year 2022 Outlook of $30 Million in Revenue CHARLOTTE, N.C., Aug. 23, 2022 (GLOBE NEWSWIRE) — LiveToBeHappy, Inc. (OTC: CAVR) (“LTBH” or the “Company”), a vertically integrated lifestyle services company, today announced financial results for the second quarter ended June 30, 2022.   Recent Company HighlightsRevenues increased 35% year-over-year to $5.4 million in the first six months of 2022 Achieved positive net income of $274 thousand in the second quarter of 2022 compared to a net loss of $152 thousand in the prior year quarterManagement Commentary “The significant increase in year-to-date revenue and positive net income in the second quarter is a reflection of the significant transformation that LTBH has undergone over the last year,” said Kevin Cox, Chief Executive...

Continue reading

Sachem Capital Corp. Announces Closing of Public Offering of $35.0 Million of 8.00% Notes

BRANFORD, Conn., Aug. 23, 2022 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) announces the closing of its previously announced registered public offering of $35.0 million aggregate principal amount of 8.00% unsecured, unsubordinated notes due 2027 (“Notes”). The net proceeds of the offering are estimated to be approximately $33.7 million after payment of underwriting discounts and commissions and estimated offering expenses payable by the company. Sachem has granted the underwriters a 30-day option to purchase up to an additional $5.25 million aggregate principal amount of Notes to cover over-allotments, if any. The over-allotment option expires September 16, 2022. The Notes will rank pari passu with all the company’s unsecured, unsubordinated indebtedness, whether currently outstanding or issued in the future....

Continue reading

Amergent Hospitality Announces Opening of Jaybee’s Chicken Palace

CHARLOTTE, N.C., Aug. 23, 2022 (GLOBE NEWSWIRE) — Amergent Hospitality Group (OTCQB:AMHG) (“Amergent” or the “Company”), owner, operator and franchisor of multiple nationally-recognized restaurants, today announced the launch of Jaybee’s Chicken Palace in Portland Oregon. Hatched from the former Waddle’s landmark location on Jantzen Beach, Jaybee’s Chicken Palace offers the local area with a dine in or take out concept offering gaming, cocktails and hand-breaded chicken sandwiches. Amergent Hospitality Group’s President, Fred Glick, stated, “We’re pleased to announce the grand opening of our new Jaybee’s Chicken Palace and offer our version of hand-breaded, crispy, spicy, tasty and fried chicken sandwiches and sides. The Jantzen Beach community has been good to us over the years, we expect this location...

Continue reading

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic targets Provisional patent applications have been filed in the United States (US) to seek protection for these new inventions A potential therapeutic marker known to be modulated by ATL1102 in DMD patients has been identified as suggestive of its therapeutic potential as a treatment for Long COVID-19 Collaboration with global leader in the clinical research of neurological aspects of Long COVID-19 Dr Koralnik to continue with application for grant funding Company plans to review its new patent applications with targeted pharmaceutical and diagnostic companies for potential commercial discussionsNew York, NY, Aug. 23, 2022 (GLOBE NEWSWIRE) —...

Continue reading

Fresh Vine Wine Premium Tasting, Lower Sugar Wines Now Available in Hawaii

The Aloha State marks another key step in the producer’s national expansion plans Cabernet Sauvignon, Chardonnay, Pinot Noir and Rosé available immediately, with other varietals to follow MINNEAPOLIS, Aug. 23, 2022 (GLOBE NEWSWIRE) — Fresh Vine Wine, Inc. (NYSE American: VINE), the leading producer of lower carb, lower sugar, and lower calorie premium wines in the United States, today announced that its wine varietals are now available in the state of Hawaii. Fresh Vine Wine’s Cabernet Sauvignon, Chardonnay, Pinot Noir and Rosé varietals are available immediately, with its Sauvignon Blanc and Brut Rose Sparkling varietals to follow shortly. Fresh Vine Wine’s varietals are being distributed in Hawaii through Southern Glazer’s Wine and Spirits, the premier beverage distributor for wines, spirits, beer, CBD and non-alcoholic...

Continue reading

Green Energy Group (Seabird Exploration Plc) – Invitation to Presentation of Second-Quarter Results for 2022

Green Energy Group (Seabird Exploration Plc) will publish its second quarter results for 2022 on Wednesday, 31 August, at 08:00 CEST. A live audiocast will take place the same day at 10:00 CEST. There will be a Q&A session at the end of the presentation, and written questions can be submitted through the audiocast solution. To join the live audiocast, follow the link below. Please note that a recorded version will be available shortly after the presentation by using the same link. https://teams.microsoft.com/l/meetup-join/19%3ameeting_NDQ1NDFlMGMtNWM3ZC00MzhjLTg5YzAtNGY4M2Y3ZTNlZjE4%40thread.v2/0?context=%7B%22Tid%22%3A%2265f51067-7d65-4aa9-b996-4cc43a0d7111%22%2C%22Oid%22%3A%22564fb45b-e0eb-4105-8cee-b6bcdb2a390c%22%2C%22IsBroadcastMeeting%22%3Atrue%2C%22role%22%3A%22a%22%7D&btype=a&role=aFor further queries contact: CEO,...

Continue reading

Stephenville Claims Form Part of Atlas’ Planned Upcoming Triple Point Spinout

Atlas Salt’s Advanced Projects in the Bay St. George Sub-Basin Atlas Salt’s Advanced Projects in the Bay St. George Sub-BasinST. JOHN’S, Newfoundland and Labrador, Aug. 23, 2022 (GLOBE NEWSWIRE) — Atlas Salt Inc. (TSXV: SALT) (OTCQB: REMRF) (the “Company” or “Atlas Salt”) is pleased to provide a corporate update with the leaders of Canada and Germany expected to sign a “Hydrogen Accord” at a news conference scheduled for early this evening (local time) in Stephenville, Newfoundland. In addition to its flagship Great Atlantic Salt Project, approximately 25 km south of Stephenville, Atlas owns 100% of the Fischell’s Brook salt deposit, Newfoundland and Labrador’s only known salt dome with clean hydrogen storage potential. Fischell’s Brook is part of a 226 sq. km land package outside of Great Atlantic on the west coast of Newfoundland,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.